AMI Clinical Trial
Official title:
Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent
The trial aims to evaluate 12-month long-term efficiency of Excel stent in the treatment of coronary heart disease and inhibition of restenosis after coronary artery stenting as well as a 12 months' long-term safety after the cessation of clopidogrel as an anti-platelet drugs used for 6 months after the implantation of degradable drug coating stent.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02793934 -
The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
|
||
| Recruiting |
NCT05122455 -
Effects of Edoxaban on Platelet Aggregation
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05201274 -
Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI
|
N/A | |
| Completed |
NCT00289237 -
Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease
|
N/A | |
| Recruiting |
NCT05764057 -
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
|
Phase 3 | |
| Recruiting |
NCT04485988 -
Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
|
||
| Terminated |
NCT00670228 -
Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction
|
Phase 3 |